EGFR and non-small cell lung carcinoma: Next, we used the surface under the cumulative ranking curves (SUCRA), a popular ranking method, which considers the ratio of the area under the cumulative ranking curve to the total area in the plot, to identify which therapeutics had the best effects on PFS of patients with NSCLC harboring EGFR-activating mutations as a first-line therapy.